Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MHRA approves Opdivo plus Yervoy for unresectable malignant pleural mesothelioma

pharmatimesAugust 06, 2021

Tag: MHRA , Yervoy , MPM , BMS

PharmaSources Customer Service